尚荣医疗收盘上涨2.57%，滚动市盈率150.86倍，总市值33.74亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Shangrong Medical, which has a current PE ratio of 150.86, significantly higher than the industry average of 51.42 [1][2] - As of July 7, Shangrong Medical's stock closed at 3.99 yuan, marking a 2.57% increase, with a total market capitalization of 3.374 billion yuan [1] - The company has seen a net inflow of 10.55 million yuan in principal funds on July 7, with a total inflow of 9.69 million yuan over the past five days [1] Group 2 - Shangrong Medical reported a revenue of 280 million yuan for Q1 2025, reflecting a year-on-year increase of 30% [2] - The net profit for the same period was 13.96 million yuan, showing a year-on-year growth of 0.58%, with a sales gross margin of 15.27% [2] - The company is recognized as a national high-tech enterprise and has accumulated over 180 patents, which contribute to its ongoing development [1]